Artal Group S.A. Spring Works Therapeutics, Inc. Transaction History

Artal Group S.A.

$214 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $3.69 Million - $4.87 Million	-102,322 Reduced 7.23%	1,313,026 $49.5 Million
Q1 2024 May 13, 2024	SELL	$36.5 - $52.5 $7.3 Million - $10.5 Million	-200,000 Reduced 12.38%	1,415,348 $69.7 Million
Q4 2023 Feb 09, 2024	SELL	$18.94 - $37.24 $3.81 Million - $7.5 Million	-201,272 Reduced 11.08%	1,615,348 $59 Million
Q2 2023 Aug 11, 2023	SELL	$23.15 - $32.71 $16,876 - $23,845	-729 Reduced 0.04%	1,816,620 $47.6 Million
Q1 2023 May 12, 2023	SELL	$24.97 - $34.05 $4.56 Million - $6.22 Million	-182,651 Reduced 9.13%	1,817,349 $46.8 Million
Q4 2022 Feb 13, 2023	SELL	$21.73 - $28.72 $1.16 Million - $1.53 Million	-53,403 Reduced 2.6%	2,000,000 $52 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $27.8 Million - $45.7 Million	1,153,403 Added 128.16%	2,053,403 $58.6 Million
Q2 2022 Aug 11, 2022	BUY	$18.36 - $60.07 $918,000 - $3 Million	50,000 Added 5.88%	900,000 $22.2 Million
Q4 2021 Feb 11, 2022	BUY	$53.3 - $75.84 $13.3 Million - $19 Million	250,000 Added 41.67%	850,000 $52.7 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $6.27 Million - $8.83 Million	100,000 Added 20.0%	600,000 $38.1 Million
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $6.75 Million - $8.56 Million	100,000 Added 25.0%	500,000 $41.2 Million
Q1 2021 May 14, 2021	SELL	$65.1 - $93.59 $3.25 Million - $4.68 Million	-50,000 Reduced 11.11%	400,000 $29.4 Million
Q4 2020 Feb 11, 2021	BUY	$48.36 - $77.92 $7.98 Million - $12.9 Million	165,000 Added 57.89%	450,000 $32.6 Million
Q3 2020 Nov 13, 2020	SELL	$36.14 - $51.99 $542,100 - $779,850	-15,000 Reduced 5.0%	285,000 $13.6 Million
Q2 2020 Aug 14, 2020	SELL	$22.98 - $48.57 $1.15 Million - $2.43 Million	-50,000 Reduced 14.29%	300,000 $12.6 Million
Q4 2019 Feb 13, 2020	BUY	$17.74 - $39.52 $735,748 - $1.64 Million	41,474 Added 13.44%	350,000 $13.5 Million
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $5.8 Million - $8.58 Million	308,526 New	308,526 $6.69 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

Vanguard Group Inc Valley Forge, PA

6.71M
Shares

$262 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.62M
Shares

$219 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

3.84M
Shares

$150 Million
4.54% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.52M
Shares

$137 Million
0.01% of portfolio
Boxer Capital, LLC San Diego, CA

3.42M
Shares

$134 Million
5.82% of portfolio

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Account